Cannabis once grew in secret, traded by murderous cartels and smoked by consumers who risked jail. Now, countries all over the world have licensed the drug for medical purposes. Ten American states have so far legalised its recreational use, and pioneering Uruguay was recently joined by G7-member Canada in the legal-weed club. Parliaments from Mexico to South Africa to New Zealand are currently debating reforms of their own.
Yet the repeal of prohibition marks the start of complex arguments:
- How to regulate both medical and recreational cannabis?
- For bureaucrats-how to tax it, which varieties to allow, who should sell it?
- Can social equity legislation help empower communities that have been disproportionately affected by the drug war?
- Will regulation finally force the cannabis industry to 'go green'?
Join editors from The Economist on June 5th, Toronto at the Cannabis Summit to network with policymakers, investors, technology thought leaders, scientists, pharma companies and entrepreneurs from all over the world to dissect and analyse new science and innovations around marijuana and determine how to shape well-regulated cannabis markets across the globe.
Earlybird Rate (Displayed in USD) - Expires April 19th: CAD 895.0
Speakers: Barbara Brohl, founder, BJ Brohl Strategies, Karan Wadhera, managing partner, Casa Verde Capital, Beau Kilmer, co-director, RAND Drug Policy Research Center, RAND corporation, Cromwell Coulson, chief executive, OTC Markets Group, Sebastian St. Louis, chief executive, Hexo Corp.